Since most of AD patients (>95%) do not carry either FAD mutations nor FAD gene overexpression (sporadic AD), current cellular AD models with FAD mutations may not be suitable for modeling sporadic AD patients. The gene discussed is PSEN1; the disease is Alzheimer disease.